The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...
Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...
Hosted on MSN2d
Neurocrine Wins FDA Approval For Genetic Disorder DrugNeurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal disease in decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback